The study, titled “Development and progression of proteinuria in dogs treated with masitinib for neoplasia: 28 cases (2010 – 2019)”, also suggests that a urine protein: creatinine greater than 0.5 should prompt reassessment within one week.
For the study, the clinical records of 38 dogs referred to a single university teaching hospital between 2010 and 2019 for treatment of neoplasia with masitinib were retrospectively evaluated.
Data was collected at masitinib initiation and at various timepoints following the start of treatment.
Data gathered included the masitinib dose given and any changes to medication administration or dosing since the previous visit, presence of gross disease and the results of haematology and biochemistry profiles, urinalysis and urine cultures.
Urinalysis results were only included if they were performed at a reference laboratory.
At each timepoint, the urine was classified as non-proteinuric (UP:C ≤0.5) or proteinurinc (UP:C >0.5). Proteinuria was then categorised as likely pre-renal, post-renal, physiological renal or pathological renal.
Dogs were grouped based on the presence or absence of proteinuria at baseline. Non-proteinuric dogs were further divided, based on whether proteinuria developed following treatment during the study.
Of the 28 dogs in the study, five were being treated for epitheliotropic lymphoma, one for vulval lymphoma, one for malignant melanoma and 21 for mast cell tumours.
Twenty-two (79%) dogs were non-proteinuric and six were proteinuric at baseline.
Of the dogs that were non-proteinuric at baseline, four (18.2%) developed proteinuria within one month of treatment initiation. Median time to first detection of proteinuria was 14.5 days (range: 13 to 31).
Of the dogs with pre-treatment proteinuria (n=6), masitinib treatment was discontinued due to lack of efficacy in three dogs, and three were euthanased during treatment, two for disease progression and one for an unknown reason.
Dr Margaux Kuijlaars, corresponding author for the paper, said: “Patients developing proteinuria should be investigated to exclude non-renal causes. This should allow for more informed recommendations on the monitoring and management of proteinuria and further masitinib treatment in these patients to be made. Masitinib treatment can be considered in patients with pre-treatment proteinuria and does not inevitably cause worsening of proteinuria.
“The findings of this study add to the evidence base for the use of masitinib in treating neoplasia in small animal patients. The use of masitinib in dogs in this study was off-licence as C-KIT MCT expression was not determined, and many dogs were treated for other tumours.”
Nicola Di Girolamo, Editor of JSAP, said: “Little is known about which dogs are predisposed to becoming proteinuric following treatment with masitinib for neoplasia. Due to the small number of dogs in this study that developed proteinuria, conclusions about predisposing factors cannot be definitely drawn.
"The findings of this study add to the evidence base and demonstrate the need for larger, prospective trials including a control population and longer period of follow-up.”
The full article can be found in the August issue of the Journal of Small Animal Practice and can be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13305. It is open access and can be freely accessed by anyone.
Reference
The survey was sent to all UK veterinary practices on the 25th November with a deadline to respond by the 1st December and received 186 responses, a response rate of 6%.
The survey found that during this period:
Lizzie Lockett, RCVS CEO, said: “Thank you once again to all the practice staff who took the time to complete this survey, it really is very useful for us to have a clear picture of how coronavirus and its restrictions are affecting day-to-day activities, as it has an impact both on our decision-making and policies, and what we can tell others about the impact on the professions, such as the UK and national governments.
"The overall picture from this survey is that, while for most it is not business as usual, veterinary practices and members of the professions are, to an extent, getting used to the disruption and have plans and policies in place to help mitigate the impact of the mosaic of different restrictions across the UK.
"While there is hope on the horizon with the start of the roll-out of coronavirus vaccines, we will continue to review and keep up-to-date our advice and guidance to ensure that you can practise to the best of your abilities, while keeping safe and within the rules.
“Of course, we also recognise the toll that the pandemic has taken on many people’s mental health and wellbeing, and this is reflected in some of the more concerning statistics around the impact that staff absences can have on the rest of the team.
"We also asked practices what might help them manage from a staff mental health and wellbeing point of view, and will take these suggestions into account when planning further support via our Mind Matters Initiative mental health project. In the meantime, we would like to remind those who are feeling stressed or are in distress that there are sources of help available during these difficult times – these can be found at www.vetmindmatters.org/help-links/help-during-covid-19/.”
The full report of the survey is available to view at www.rcvs.org.uk/publications
The company says it has made the test available in response to customer demand and growing evidence that in rare cases pets living with COVID-19-positive humans can be at risk of infection.
The test will be available to veterinary surgeons in North America this week and will roll out across most of the world in the coming weeks, via the company's worldwide network of laboratories.
Jay Mazelsky, President and Chief Executive Officer of Idexx Laboratories said: "We have continued to monitor the rapidly evolving public health crisis worldwide, paying special attention to the effects on pets.
"While there is currently no evidence that dogs or cats play a role in transmitting the disease to humans, it became clear offering the test was the right thing to do when we saw clinical evidence that pets—especially cats and ferrets—can in rare cases be at risk for infection. And, we heard from our customers around the globe that veterinarians needed a testing option."
Idexx recommends the test is used when three specific criteria are met:
Idexx says leading health authorities agree with the company that transmission of the SARS-CoV-2 virus is primarily person-to-person and advise against testing asymptomatic pets. Since mid-February, the company has tested over 5,000 specimens for the virus, from cats, dogs, and horses with respiratory symptoms in 17 countries. To date, it has found no positive results, suggesting that dogs and cats living with infected people generally remain uninfected, except in rare and isolated cases.
For information about the Idexx SARS-CoV-2 (COVID-19) RealPCR Test for pets, visit idexx.com/covid19-pet-test.
The new course is called Veterinary Science: Accelerated Graduate Entry (BVSc), and will welcome its first students in September 2019.
The school says the course responds to calls for innovation in veterinary education while upholding current best practice in adult education to support independent, self-directed, and collaborative learning.
Designed for graduate learners, the programme will see students guided through case-based, tutor-facilitated teaching and learning.
The programme is based on a collaborative approach, where students can work together to gain practical experience from BVS clinics and clinical research.
Students will be taught in new purpose-built teaching facilities at the school in Langford, North Somerset.
The Langford Campus also encompasses equine and small animal hospitals, a dairy farm, diagnostic laboratories, and farm animal, small animal and equine practices.
Professor Richard Hammond, Head of Bristol Veterinary School said: "As someone who was a graduate entry veterinary student myself, I feel passionately about providing opportunities to those who make the choice to train as a vet later in their educational journey.
"This new programme, delivered in purpose built, state-of-the-art facilities will focus on a more student-centred, case-based approach in small groups and with lots of tutor contact and support. We look forward to welcoming our first cohort of students to Bristol in September 2019".
The case was brought by the College after a member of the public raised a 'concern' relating to Mrs Mullen's practice in December 2015. The concern was not pursued by the College.
However, during its initial investigation, the RCVS case manager ascertained that contrary to the requirements of the Code of Professional Conduct, Mrs Mullen did not have PII.
In January 2016 Mrs Mullen was advised by the College that, in order to comply with the Code, she needed to ensure her professional activities were covered by PII or equivalent arrangements.
The matter was considered by the Preliminary Investigation Committee which asked, in October 2016, that Mrs Mullen produce evidence that she was now compliant with the requirement to have PII or equivalent. Mrs Mullen responded in November 2016 confirming that she had not put in place such arrangements.
The case was then referred to the Disciplinary Committee in January 2017.
During the hearing it was determined that, during the relevant time period (from November 2015 to November 2016) Mrs Mullen was practising but did not have professional indemnity insurance in place and therefore was in breach of the Code.
Mrs Mullen, who represented herself, told the Committee that she admitted that she did not have PII. She explained that she was 'ethically and morally opposed to it' as she felt that it did not give fair compensation to claimants and did not know it was a requirement of the Code of Professional Conduct until she was informed by the College in January 2016.
When giving oral evidence as to equivalent arrangements she disclosed that she kept significant funds in a bank account; these were not however specifically earmarked for use in the event of any possible claims, and were also required to pay practice expenses.
In light of evidence produced by the College and her own admissions, the charges against Mrs Mullen were found proved and she was found guilty of disgraceful conduct in a professional respect.
In coming to this decision Chitra Karve, chairing the Committee and speaking on its behalf, said: "The respondent failed to have PII in place for a period of about 12 months as specified in the charges. Moreover, she failed to remedy the situation when advised in January 2016 by the College that she was in breach of the Code and the supporting guidance. This remains a continuous course of conduct, which has still not been remedied. The respondent has chosen not to read the Code, or the supporting guidance, until very recently, in relation to her obligation to have PII or equivalent arrangements in place, and she failed to heed the advice of the College that she must rectify the position."
In considering the sanction the Committee took into account mitigating and aggravating factors. Aggravating factors included the fact that the misconduct was sustained over a significant period of time and that limited insight was shown by Mrs Mullen. While she did begin to display limited insight into the significance of her misconduct, the Committee said that this insight was "hampered by her ambivalence towards the College and the systems that regulate the veterinary profession."
In mitigation the Committee took into account Mrs Mullen’s long and unblemished career and the fact she was a sole practitioner who reported challenging personal circumstances and provided a unique service to a niche group of clients.
However, Chitra Karve said: "The Committee is unable to overlook the Respondent’s lack of commitment to obtaining PII or equivalent arrangements, even after being advised by the College that this was essential. The Committee is aware that a suspension could adversely affect her practice and her clients that she uniquely serves. However the Committee thinks it is necessary to send a clear message to the respondent and the public, that failure to obtain PII or equivalent arrangements is wholly unacceptable."
She added: "Accordingly, the Committee directs the Registrar to suspend the respondent’s registration for a period of two months. The Committee considers that this period of suspension will give the respondent an opportunity to rectify her breaches of the Code in relation to PII… and to reflect upon her attitude towards the College and the appropriate regulation of the veterinary profession."
IVC says the new brand will allow better communication for equine teams within the IVC Evidensia group as well as collaboration with the wider equine world.
IVC Evidensia Equine Vets range from graduates to European Specialists, working in both dedicated equine and mixed practice, with all practices supported by the four large equine veterinary referral hospitals in the UK: Donnington Grove Veterinary Group, Fyrnwy Equine Group, Oakham Veterinary Hospital and Pool House Equine.
IVC says the brand's mission is to put the welfare of horses at the heart of everything it does, to providing outstanding continuity of care for all equine species and breeds across the network, to be at the forefront of continual professional development, supporting and facilitating the development of clinical and leadership skills across all their equine teams, and to build the leading network for equine veterinary care across Europe.
Richard Stephenson, Chair of the IVC Evidensia Equine Clinical Board, said: "Our network brings together all forms of equine work from ambulatory practice to some of leading UK equine referral centres.
“It gives support to all our staff in their careers. We facilitate clinical development from the graduate academy, through intern training, residencies and training up to European Diplomat level.
“We provide coaching and leadership, flexible roles and friendly, inclusive teams.”
For more information, visit https://www.ivcevidensia.co.uk/Equine or stand B01 at BEVA 2021 congress.
The figures came from an analysis of over 100,000 calls made to VidiVet by owners when their normal practice was closed, between 2021 and 2024.
So far in 2024 36% of VidiVet’s calls have been gastrointestinal cases, 25% skin cases, 14% musculoskeletal and 3.7% post-surgical issues.
The advice given to many of these cases was that an emergency visit to an out-of-hours (OOH) clinic wasn’t necessary, but to monitor at home then attend their own vet practice for any workup, diagnostic tests, medication etc.
The company is now encouraging practices to consider using it's triage service over Christmas, when practices and emergency clinics often experience an increase in OOH workload.
This, it says, is a win-win situation as it relieves pressure on OOH clinics, brings revenue back to veterinary practices and also saves clients money, stress and time.
Ben Sweeney, Veterinary Surgeon, CEO and Founder of VidiVet said: “When I launched VidiVet, vet practices were understandably concerned that digital vet services could drive work away from their clinics.
"We hope this new data shows the opposite, and how it can directly benefit practices in a way they might never have imagined.
"What VidiVet has actually done, as was our belief from the get-go, is to drive the bond with clients even closer as well as providing a revenue opportunity for the practice whilst prioritising pet health and welfare.
"This is because the added benefit of a service like ours alleviates part of the immense burden on clinical teams from front of house to the surgical teams, without them losing control.
Kate Higgins MRCVS, owner of Village Vets Crosby & Formby, said: “Over the last six months we’ve saved our clients collectively an estimated £75,000 in emergency vet fees by using VidiVet.
"They were able to be reassured out-of-hours whether their pet did or didn’t need emergency treatment.
"Those that did were able to be treated swiftly by an out-of-hours clinic, and those that did need treatment but not urgently, were able to come to us during our usual working hours, not incurring emergency fees.
"What is even better for us (and our clients) is that we have the case notes from their call with VidiVet ready and waiting for us when we’re open, so we’re up to speed with what the issue has been and what advice has already been given – which is a crucial time saver for both parties.”
www.vidivet.com
Photo: Emma Paine
The ten-minute online survey aims to gather a snapshot of horse health over the period of a week.
The results help to identify trends in endemic equine diseases and help the Blue Cross steer equine awareness, education and research.
This year the survey includes some welfare questions to help guide knowledge in response to what the charity calls 'the UK’s horse welfare crisis'.
The National Equine Health Survey is run by the Blue Cross in partnership with the British Equine Veterinary Association. Dodson and Horrell is helping to cover the costs of running the scheme.
Supporters of the survey include the British Horse Society, Horse Trust, Redwings and the Pony Club.
Medal-winning riders Mary and Emily King, and Yazmin Pinchen (pictured right) also support the survey.
Visit www.bluecross.org.uk/NEHS or email NEHS@bluecross.org.uk to register and take part, which carries the chance of winning prizes including Star Lister Clippers, a Lister Adagio Trimmer and some Burford Ariat boots.
The paper was written by FEDIAF’s Scientific Advisory Board, comprised of independent academics from leading European universities, with the aim of informing both the industry and the public.
Based on recent scientific data, the paper explains the different life expectancies of dogs related to their size, and defines when "old age" sets in. It explains how changes in the digestive tract can affect food intake, how food texture may become a crucial factor, and how aging can lead to changes in energy metabolism and alter the nutrient requirements of senior dogs. It also offers practical guidance to pet owners for feeding an older dog.
Dr Thomas Brenten, Chairman of FEDIAF’s Nutrition & Analytical Science Group said: "Age-related changes in cognitive functions, behaviour, skin, digestive tract, cardiovascular system, respiratory tract, degenerative joint and skeletal function, as well as urinary disorders are the most common issues concerning older dogs. Many of these can be addressed via nutrition."
The paper can be downloaded in the new section on science on FEDIAF’s website: https://tinyurl.com/fediaf-senior-dogs.
The company says it has already used part of the funding facility to acquire six practices – four in Wales and two in South London, with the aim to attain many more practices in 2017 across the UK.
Medivet now has 169 veterinary practices across the country, making it the fourth largest veterinary group in the UK.
Will Taylor, Corporate Relationship Manager for HSBC in Thames Valley, said: "It is great to see that Medivet has gone from strength-to-strength over the past few years, with an ambitious business. HSBC has enjoyed a long-standing and highly effective business relationship with Medivet and this latest deal will allow the business to carry out its aspiring acquisition plan and continue to grow at a rapid pace."
Dr Arnold Levy, Chief Executive Officer at Medivet, said: "This latest round of funding will allow us to take up a vast amount of opportunities that have become available to us and accelerate the pace of acquisitions of further practices across the country. Last year we acquired over 50 new sites and this year we plan to attain even more, which is significant progress for our business and testament to our strong financial backing."
The Prince's Trust 'creates life-changing opportunities' for those aged 11-30 and Nick has long-held a passion for making a difference to young lives. He has set up three charities for young people: with learning disabilities; who want to campaign to change the world; and who want to break down the barriers to enjoying nature and the outdoors.
Nick has led the RCVS since September 2012. During his tenure, developments at the College include a new Royal Charter, major governance reform, improved regulation of veterinary nurses, the instigation of Vet Futures, the introduction of the alternative dispute resolution service, significant evolution within the Practice Standards Scheme, the refocusing of RCVS Trust into RCVS Knowledge, the launch of Mind Matters, and the recognition of the College as a Great Place to Work.
Nick said: "It has been a great privilege to be CEO of the College and to work with such amazing staff, such a progressive Council and such a decent and caring profession. It is no surprise to me that vets and vet nurses are among the most trusted professionals in this country, and in my view this is due to their professionalism and to the excellence of the Royal College in maintaining and advancing standards. I hope I have played my part in helping the College and the profession navigate through a period of great change and preparation for significant change to come.
"At The Prince’s Trust I will be focused on the next generation, helping to give young people the confidence and purpose they need to make a success of their lives and the world around them. I know from my own personal experiences of school, and the various charities with which I have been involved, how many young people are not given the best chance in life. I cannot think of a better mission to take on."
RCVS President Chris Tufnell said: "I feel very fortunate to have worked closely with Nick over his five years with the RCVS; he has made a tremendous contribution to the College and our professions. With his energy and drive, he has infused the College with a culture of openness, engagement and dedication and has inspired the team through some impressive achievements.
"Nick’s leadership will enable vets and veterinary nurses to fulfil their potential and it's fitting that he's moving on to a role which benefits the lives of others. Meanwhile, there's a considerable amount of important work being done by the RCVS and I am confident that we have a strong team at Belgravia House to manage this until the new CEO is in post."
The RCVS says its Operational Board will be reflecting on Nick’s successes and the future needs of the College, before developing a specification for the new CEO and a recruitment process over the coming weeks.
Virbac Animal Health has launched Microbex, a POM-V shampoo for the control of Malassezia proliferation and associated clinical signs.
The arrival of Microbex extends the Virbac shampoo range to eight, providing vets with the most comprehensive specialist options in the management of skin conditions, says the company.
Microbex (POM-V) contains 3% chlorhexidine. Product manager Chris Geddes MRCVS said: "Chlorhexidine at this level provides a complete treatment for Malassezia.
"The shampoo also has a flexible application schedule and simple dosing cap, both of which are designed to help improve client compliance and treatment success rate.
Chris added: "Microbex is available in 200ml bottles making it an attractive purchase option for clients."
Further details can be found in the NOAH compendium http://www.noahcompendium.co.uk/. For details on launch promotion contact your local Virbac territory manager or call Virbac on 01359 243243.
In addition, less than half of those surveyed knew the correct temperature for vaccine storage, showing there is a lack of knowledge surrounding standard procedures.
Paul Williams, MSD Animal Health UK technical manager for ruminants said: "Failing to maintain the correct fridge storage temperature compromises vaccine effectiveness and consequently animal health.
"In a significant number of farm fridges monitored, the temperature was elevated to 80C for long periods of time, with the maximum fridge temperature recorded being 240C.
"In the worst cases, over 60% of fridges had been at 0 0C or below 0 0C long enough for vital contents to freeze. When the temperature is too high, vaccines become ineffective. If frozen, the vaccine is destroyed.
"This research shows we have work to do in educating customers about how to store vaccines and I encourage all farmers to check their farm fridge temperatures.
"To promote better practice, we’ve launched an awareness campaign called Fridge Check to educate farmers on the importance of storing vaccines correctly.
"The campaign is being promoted by Disease? Not On My Farm!, an initiative helping farmers take a more proactive approach to preventing disease on farm."
To find out more, visit the Disease? Not On My Farm! Facebook and Twitter pages or follow the hashtag #FridgeCheck for more information about how to store vaccines correctly.
There is a need to raise farmers’ awareness of correct vaccine storage temperatures. Williams P. (MSD Animal Health), Paixao G. (University of Bristol).
The service offers Galen myotherapy, a form of massage, together with diet, exercise, nutraceutical and weight advice, house management advice, and an owner awareness and pain indicator assessment.
Hannah, who spent 14 years in small animal practice, said: "During a very bad week in practice I put two dogs to sleep in quick succession who’d both gone off their back legs. They were mentally there but their bodies had given up. I realised that osteoarthritis needed to be approached much more thoroughly and at a much earlier stage in a dog’s life."
CAM’s home-visiting service assesses arthritic dogs in the calm of their own surroundings. Hannah says that treatment aims to improve a dog’s posture and movement, support their ability to exercise and give owners the tools they need to make life easier for arthritic dogs. She added: "In a consultation, it can be very difficult to get all the information across to an owner whose dog has just been diagnosed with arthritis. CAM is a unique service that fills a gap. It aims to go into a dog’s home and make adjustments that will be good for that individual long-term."
Hannah says that the new service is offered alongside the owner's existing veterinary surgeon, who will need to give consent and prescribe any other treatments, such as NSAIDs, which are needed as part of the larger treatment plan. In other words, it's an additional service that vets can offer to their clients, ensuring they are doing everything they can to help their many arthritic patients.
Hannah said: "Arthritis is a household name, it's massively prevalent in humans and there are huge support services for people dealing with the chronic pain associated with the condition. As a profession we know that dogs with arthritis suffer the same pain – it’s time we had a proper service for them too. CAM is that service – a tailored, multimodal approach to help successfully manage these patients."
Canine Arthritis Management (CAM) is currently available to dog owners throughout Sussex. If you would like to know more, email info@caninearthritis.co.uk
The company says that Daxocox achieves significant improvement of clinical signs associated with the pain of osteoarthritis (OA) in dogs1,2 and also helps reduce the risk of breakthrough pain.
Breakthrough pain is defined as “an abrupt, short-lived, and intense pain that breaks through the analgesia that controls pain”3. Risk factors for breakthrough pain in cases of canine OA include poor owner compliance, variable plasma drug levels between doses, natural or exercise induced flare-ups and disease progression.
According to research carried out by the company, veterinary surgeons estimate that nearly half of their canine OA cases on daily NSAIDs experience breakthrough pain4, whilst owners put the figure much higher at 80%5.
Animalcare says that as well as compromising patient welfare and increasing the risk of clinical consequences such as wind-up pain (hypersensitisation), breakthrough pain risks owners losing confidence in their vet and/or the recommended treatment plan for their dog. This may lead owners to independently stray from the treatment plan, with potentially damaging consequences. In its research, 87% of vets agreed that avoiding breakthrough pain is critical to the management of canine OA4.
Animalcare adds that because of the pharmacology, there is no risk of risk of over-accumulation or need for mandatory treatment ‘breaks’6. Also, adverse effects were found to be no different from any other NSAID1,2 and there was no increase in treatment-related adverse effects at up to 5 times the recommended dose7, so Daxocox has a broad margin of safety and is well tolerated by dogs7.
James Beaumont, marketing manager at Animalcare said: “Daxocox’s weekly administration of a flavoured tablet addresses some of the challenges of managing canine OA that I’m certain most vets will identify with. Breakthrough pain is a real problem and by being able to provide consistent pain control, in a compliance friendly formulation, Daxocox is a real game changer for canine OA management.
For more information, visit: www.animalcare.co.uk, or contact your local Animalcare territory manager, or Animalcare’s head office on 01904 487687.
References:
In a European first, Pfizer Animal Health is conducting a major study in over 2000 dogs with Trocoxil, its new NSAID which delivers continuous analgesia for a month.
According to the company, Trocoxil has already been granted a licence by the EMEA and pre-authorization studies have already shown once-monthly Trocoxil to be at least as safe and effective as daily carprofen. However, the monthly dosing regimen represents such a big step from the currently used approach of daily NSAID dosing, that Pfizer has decided to initiate the study before launching the product in order to closely monitor and manage the introduction of Trocoxil to the veterinary market.
Jolian Howell, Associate Director Companion Animal Marketing for Pfizer said: "A drug with such a unique dosing regimen should be introduced in a controlled and managed way, and this study is part of that commitment by Pfizer Animal Health."
This large post-approval study, conducted under veterinary control as a User Experience Study, will enable a similar comparison with carprofen to be made in a much larger patient population. In fact it will be sufficiently large to provide product-specific safety information, such as any differences in the incidence of side-effects.
The randomised, parallel group study is being conducted in more than 100 veterinary clinics throughout France, Germany and the UK. Each dog will receive up to 6 months of treatment during which time it will be assessed every month by the veterinary surgeon.
Trocoxil, a preferential COX-2 inhibitor, has a unique pharmacological profile which means that a single oral dose provides continuous pain relief for a whole month.
Jolian added: "This study will provide veterinary surgeons with an opportunity to experience the benefits of using Trocoxil to treat OA continuously over a period of months. It will also give them the opportunity to assess the benefits this offers the owner."
Having had a three-month sabbatical working at Fitzpatrick, Jonathan decided to relocate from New Zealand where most recently he'd been Head of the Companion Animal Group at Massey University.
Jonathan said: "My prime passion is working directly with animals and their families in a supportive and exceptional clinical setting. I enjoy pushing boundaries and not accepting the status quo. I want to identify better ways of improving outcomes for patients, and minimising the impact of the disease (or its treatment) on an animal’s quality of life. My sabbatical at Fitzpatrick Referrals exposed me to their tremendous energy and real passion for patient and client care. From the moment the clients walk in the door, I feel there is an embrace that lets people know we truly care and want to do the best for their animal friend. I am looking forward to discovering what we can achieve together. Cancer management is such an important opportunity, with the power to change both animal and human lives positively. The direction and focus of Fitzpatrick Referrals in this area is already incredibly exciting.”
Clinical Director of Oncology and Soft Tissue, Professor Nick Bacon said: "On Jon’s first day of his sabbatical, he jumped right into the team and made an immediate positive impact. He hasn’t looked back. He carries with him such a good energy, which we all absorb and hopefully reflect back. His knowledge of implant design for dealing with defects in the mandible and elsewhere is exceptional and I am looking forward to watching that develop. I am also very pleased that Jon’s wife Sharyn is able to join the team; she is very experienced in the field of advanced imaging in humans, including Fluoroscopy and PET-CT. This is already benefitting our patients as we improve our diagnostic and treatment abilities, and get ready for the future."
Jonathan has active research interests in several clinical areas including soft tissue sarcoma, injection-site sarcoma, endoprosthetics and haemangiosarcoma. He also supports the concept of One Medicine as his PhD research into soft tissue sarcoma, haemangiosarcoma and endoprosthetics has a potential relevance in improving the understanding of treatment paradigms for humans and animals.
Dechra Veterinary Products has launched a new online fluid therapy distance-learning course for vets and nurses, to help maximise the potential of its Vetivex® fluids range.
The Fluids Knowledge Programme has been created to provide comprehensive and flexible online CPD for companion animal and equine practitioners. The coursework, which counts for six to eight hours of CPD learning, includes the latest thinking from fluid therapy specialists Dr Ava Firth, Karen Humm and Kevin Corley.
Dechra says the course combines theoretical and practical advice on fluid therapy for both small animals and horses, and can be used for training, as a refresher, and to develop thinking on fluid therapy. Self-assessment questions included within the course allow progress to be monitored throughout.
Gwenda Bason, marketing director for Dechra Veterinary Products, said: "We've spent months of research and development producing this online learning portal for professionals. It will enable vets and nurses to improve their knowledge, understanding and patient care. Being online, users can dip in and out of it as and when their schedules allow and additional costs often associated with CPD learning, such as travel or accommodation costs, are eliminated.
"When practices choose Vetivex, they're not just buying bags of fluid, they're benefitting from our investment in practice education which will improve their understanding of the role and management of fluids."
Dechra estimates the programme is worth around £400 per person, and therefore offers savings of over £3000 in CPD costs for an 8 member practice.
To find out more about the Fluids Knowledge Programme visit www.fluidtherapy.co.uk, or contact Liz Rawlings at Dechra on 01743 441 632.
The RCVS Disciplinary Committee has reprimanded and warned a Clwyd-based veterinary surgeon on charges relating to falsifying prescriptions to obtain drugs for her own use.
At the outset of the two-day hearing, Mrs Alina Grecko admitted that in 2009 she had written out three prescriptions for her own use whilst working as a veterinary surgeon at Greenfield Veterinary Surgery, Holywell, Clywd, and that this amounted to serious professional misconduct. The Committee found this to be the case, and said she was right to admit it. The Committee also said this was deliberate wrong-doing on three separate occasions and involved an obvious breach of Mrs Grecko's legal duties in relation to prescription which was bound to diminish the profession and public confidence in it. It was also a flagrant breach of the Guide to Professional Conduct for Veterinary Surgeons.
In the Committee's opinion the charge was a serious one; it involved falsehoods and disregard of legal obligations and of the profession's standards, as well as compromising another professional - a pharmacist. In mitigation, however, the Committee accepted that the offence involved no harm to any animal or person, nor risk of harm except to herself; nor was there financial gain. Mrs Grecko was a young and relatively inexperienced veterinary surgeon, and the Committee's view was that the offence was the result of her not thinking straight at a time of great stress in her personal and professional life, rather than a clearly thought out course of deliberate conduct. It was in no doubt that Mrs Grecko was genuinely remorseful about her behaviour and had insight into its seriousness.
The Committee also considered evidence relating to the circumstances in which the prescription came to be written. It accepted the general case that the original idea of self-prescribing did not come from Mrs Grecko; however, the Committee did not find that she had been encouraged or persuaded; the most that could be said was that Mrs Grecko had taken up a casual suggestion that she might write the prescription herself.
When deciding on sanction, the Committee took into account both the facts of the particular case and the mitigating factors. It reiterated that the primary purpose of the sanction is not to punish the Respondent but to protect the welfare of animals, to maintain public confidence in the profession, and to uphold proper standards of conduct and said the sanction applied must be proportionate to the nature and extent of the Respondent's conduct, and weigh the public interest with the interests of the Respondent. The Committee also said that in a case involving the writing of false prescriptions the importance of public confidence in the profession and of upholding the standards of the profession mean that the Committee would normally feel that at least a suspension from the Register should be imposed.
Having given anxious consideration to the question whether that course could properly be avoided in this case, the Committee felt able to take an exceptional course and the sanctions it has imposed are that the Respondent will both be reprimanded and warned as to her future conduct. It directed that these sanctions will remain on her record indefinitely.
Ceva Animal Health has announced that Vetergesic (buprenorphine), its long-lasting analgesic, is now back in stock and on special offer with the rest of the company's analgesic product range.
The company says it has appointed a new, dedicated Vetergesic manufacturing site and increased stock-holding facilities in order to guarantee a continuous long-term supply of the product, which is available in a 10ml vial for use in dogs, cats and horses and a 1ml single dose preparation for cats and dogs.
At the same time, Ceva has launched a spring offer on its entire analgesic product range, which runs till the end of April. For every two packs of Vetergesic, Carprodyl F or Dolagis purchased, veterinary practices will receive one pack free and for every four packs of Meloxidyl purchased, practices will receive one pack free. In addition, practices will be able to take advantage of ongoing rebates through the new CevaSave Rebate Programme.
For further information, contact your local Ceva territory manager, email analgesics-group@ceva.com or call 01494 781510.
The company says the initiative, which is targeted at veterinary professionals and farmers, will be supported by an extensive social media, advertising and PR campaign.
The social media campaign will take the form of social media content, newsletter articles and images for veterinary practices to use on their social media channels and will include information on the cost of dairy cow lameness and tips to manage lameness.
Rose Jackson BVSc DBR CertVBM MRCVS is the farm clinical director at Scarsdale Vets which has already trialled the new materials. She said: “The ‘Wave Goodbye to Pain’ social media content has ensured that we are able to post eye-catching and thought-provoking content to continue to engage with our clients and raise awareness of the ‘triple works’ approach to lameness in cows, which includes using a NSAID such as Ketofen, alongside a trim and block for a more complete recovery from lameness than trimming alone.”
The ‘Wave Goodbye to Pain’ campaign was launched following a study by Nottingham University which revealed that NSAIDs have a synergistic effect when given alongside effective hoof trimming and blocking to treat lameness1.
The study looked at claw horn disease of the hind foot and found that trimming alone resulted in a 69% rate of return to mobility without lameness in 35 days. Adding a block into an effective trimming protocol raised the success rate to 72%; trimming and administering a NSAID raised it to 76%. Interestingly, using all three techniques together - trimming, applying a block and administering an NSAID - resulted in 85% of cases being successfully resolved (Mobility score or 0 or 1).
Gemma Robinson BVM BVS MRCVS, ruminant veterinary adviser at Ceva Animal Health, said: “The study highlights that effective and prompt pain relief with NSAIDs can quickly help restore animals back to full productivity. Attitudes on the use of pain relief have changed significantly over the last 10 years and dairy farmers can have a positive influence by ensuring they recognise the value of NSAIDs and prioritise their use on-farm. It is important that vets discuss NSAIDs with their clients, both to manage illness and for routine procedures, and our ‘Wave Goodbye to Pain’ campaign will help encourage farmers to think about their current pain management plan, take action and seek help from their vet.
“Some concerns have been raised that the issues associated with antimicrobial resistance and antibiotic administration are causing farmers to avoid the use of all injectable treatments. We need to be clear that NSAIDs are anti-inflammatories, not antibiotics, and it is important they are used for pain management, fever and the clinical signs associated with many common conditions. With zero milk-withhold NSAIDs available - there really is no reason to hesitate when it comes to administering pain relief in otherwise healthy cattle.”
For more information on the ‘Wave Goodbye to Pain’ campaign visit the website designed for farmers (www.wavegoodbyetopain.co.uk), contact your local Ceva territory manager or call 01494 781510.
To request a copy of the ‘Wave Goodbye to Pain’ social media pack (including pre-developed posts and images which you can send out to your own clients), speak to your Ceva territory manager or email: cevauk@ceva.com with your name, practice name and address details.
References
The pads contain ophytrium and chlorhexidine at 3%. Ophytrium is a purified natural ingredient from Ophiopogon japonicus which, Ceva says, strengthens the mechanical skin barrier1, restores the balance of protective microbial flora2 and reduces irritation, while soothing the skin1. Chlorhexidine is both antibacterial and antifungal.
Ceva says that Douxo S3 Pyo pads, which come in packs of 30, provide antibacterial and antifungal efficacy within one minute and are free from soap, parabens, sulphates, phthalates, colourants and nanoparticles.
They are available in a new, hypoallergenic ‘summertime’ fragrance which pet owners liken to coconut and vanilla.
The pads add to the Douxo S3 Pyo range, which also consists of shampoo and a mousse.
Andrew Fullerton BVSc (Hons) MRCVS, product manager for Douxo S3 at Ceva said: "The new Douxo S3 range has been well received by both veterinary professionals and their clients since its launch, who find that the products are not only effective and well tolerated, but also easy-to-use. The Douxo S3 Pyo pads will enhance this range by offering an easy-to-administer antiseptic action while hydrating and maintaining the skin’s ecosystem.”
For further information, contact cevauk@ceva.com, your local territory manager or visit https://www.douxo.com/uk/Pet-Skin-Care/douxo-s3.
The Privy Council has overturned an RCVS Disciplinary Committee to strike Leeds-based Dr Gary Samuel MRCVS from the Register following his conviction for theft, common assault and a public order offence at Cardiff Magistrates' Court in November 2011.
The Disciplinary Committee had agreed the sanction following a hearing in February 2013, at which it decided that Dr Samuel's conviction made him unfit to practise veterinary surgery.
Dr Samuel appealed the decision and the Privy Council heard the case on 26th March.
Dr Samuel had been sentenced by Cardiff Magistrates' Court to concurrent terms of 28 days' imprisonment for theft and common assault and 12 weeks' imprisonment for the public order offence, all suspended for 12 months. He had also been ordered to carry out 140 hours' unpaid work and to pay compensation of £75 and costs of £625. The charges related to an incident involving Dr Samuel and his neighbour, described by the Privy Council as "a spontaneous outburst in the course of an angry quarrel between neighbours", for which it felt that the Disciplinary Committee's sanction of removal from the Register was "disproportionately severe."
The Privy Council felt that, in making its decision, the Disciplinary Committee followed too closely the verdict reached by the Magistrates' Court, and did not take mitigating circumstances sufficiently into account, including whether the attack by Dr Samuel on his neighbour had been provoked by racial abuse.
Delivering the Privy Council's judgment, Lord Toulson said: "It is apparent from the reasons given by the Committee, both on the question of fitness to practise and on the question of sanction, that it was considerably influenced by the fact that the magistrates imposed a suspended prison sentence.
"Although Dr Samuel pleaded guilty to the theft of the camera and he was not in entitled to go behind his plea, it is nevertheless difficult to understand on the evidence how the prosecution would have proved that there was an intent permanently to deprive [the victim] of it. In all the circumstances, it is hard to conceive that the court would have considered that the offences truly passed the custodial threshold for a person of good character, if it had not had the power to suspend the sentence... Dr Samuel's conduct was thoroughly reprehensible, but the Board [Privy Council] does not consider that its gravity was such that it would be in the interests of the public now to remit the case to the Committee".
Dr Gary Samuel will not now be removed from the Register
The Privy Council's judgment can be read in full at http://jcpc.uk/decided-cases/index.html
The ideal Christmas present for a vet to give a child has just landed on my desk.
It's the Amazing ABC Adventure by Lorna Maxwell, out now in paperback from Long Barn Books and available on Amazon here.
Each letter of the alphabet begins an eclectic list of things to be found within a delightful illustration on the facing page. There's a strong animal theme throughout the book: everything from annoyed armadillos and affectionate alligators to worried wombats and yodelling yaks.
One of those books that it's a pleasure to read a child before bed. A steal at £5.79.
The platform, which is available to Premier Pet Care Plan and Animal Healthcare clinics, is designed to help practices increase the number of sign-ups to health care plans.
Romain Regnier (pictured right), PVA’s Business Analyst Manager said: "The current situation has accelerated the need for a digital transformation.
"To help vet practices reach this goal, we have created a highly customisable digital sign-up solution, which mirrors the practice’s branding and can be used in communications to the customer, giving you more possibilities to promote your plans."
With a digital platform, practices can now encourage owners to sign up whilst waiting - socially distanced - outside, or from home.
Debbie Saunders, PVA’s Customer Experience Manager said: "It’s a two-pronged solution; reducing the impact that limited interactions with clients is having on health care plan signs ups and allowing practices to advertise their plans more efficiently.
We are encouraging practices to post about their new digital sign-up links on social media, so pet owners complete their forms anywhere. It will make a big difference to veterinary staff, reducing the amount of administrative pressure from plans but also allowing a direct call to action from advertising."
Each practice will be given unique urls, tiny urls and QR codes which link to the platform, alongside additional marketing materials. The marketing packs contain some customisable content, including social media assets, website banners and printable posters, all free to use to promote the new sign-up platform.
The digital sign-up platforms come with personalisation options, allowing practices to customise their webpage with their own logos, text, and branding, with the help of their PVA trainer.
If you are a Premier Pet Care Plan or Animal Healthcare clinic and are interested in integrating a digital sign-up form into your practice, contact your PVA trainer or call 0117 370 0300 .